NTLA
NASDAQStockIntellia Therapeutics, Inc.
$12.79-0.23 (-1.77%)
52-Week Range
$6.28
$27.98
Key Stats
Market Cap
1.5B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.02
Volume
2.6M
Avg Volume
4.6M
Performance
1M
+7.08%
3M
+40.59%
6M
+11.06%
YTD
+39.52%
1Y
+39.37%
3Y
-67.98%
5Y
-81.12%
Price Chart
ETF Exposure
NTLA is held by 78 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 4.33% |
| ARKG | ARK Genomic Revolution ETF | 3.55% |
| TYNE | Direxion Nanotechnology ETF | 2.29% |
| MOON | Direxion Moonshot Innovators ETF | 2.02% |
| ARKK | ARK Innovation ETF | 1.95% |
| WDNA | WisdomTree BioRevolution Fund | 1.51% |
| GNOM | Global X - Genomics & Biotechnology ETF | 1.16% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.11% |
| MEDX | Horizon Kinetics Medical ETF | 0.96% |
| MNTL | Tema Neuroscience And Mental Health ETF | 0.86% |
| XBI | State Street SPDR S&P Biotech ETF | 0.61% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 0.52% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 0.36% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.19% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.18% |
| IBB | iShares Biotechnology ETF | 0.13% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.12% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.12% |
| PWS | Pacer WealthShield ETF | 0.11% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.10% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.10% |
| IWN | iShares Russell 2000 Value ETF | 0.10% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.09% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.09% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.08% |
| DFAS | Dimensional - US Small Cap ETF | 0.08% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.08% |
| STSB | iShares Factors US Small Blend Style ETF | 0.06% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.05% |
| VBK | Vanguard Small-Cap Growth ETF | 0.05% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.05% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.05% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| VTWO | Vanguard Russell 2000 ETF | 0.04% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.04% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.04% |
| UWM | ProShares - Ultra Russell2000 | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| VB | Vanguard Small-Cap ETF | 0.02% |
| VHT | Vanguard Health Care ETF | 0.02% |
| DXUV | Dimensional - US Vector Equity ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.02% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.01% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.01% |
Page 1 of 2Next
About NTLA ETF Exposure
Intellia Therapeutics, Inc. (NTLA) is held by 78 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, NTLA is a widely held institutional stock. The stock currently trades at $12.79. Investors can gain exposure to NTLA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NTLA, sorted by portfolio weight.